A rapid diagnostic test for the detection of Neutrophil Gelatinase-Associated Lipocalin (NGAL), a biomarker used in clinical assessment.
Manufactured by
Hangzhou Elit Biotech Co.,Ltd.
Hangzhou, Zhejiang, China
Headquartered in Xiasha Street, Qiantang New District, Hangzhou, Hangzhou ELIT Biotech Co. Ltd. has been focusing on the research, development, production, sales and service of POCT products since its founding in 2019, providing customers with professional rapid diagnostic and chronic disease management solutions. Hangzhou ELIT Biotechnology Co., Ltd. provides IVD products in the following categories: women's health, drug abuse testing/toxicology, infectious disease identification, tumor marker testing and cardiac marker monitoring. ELIT utilizes world-leading bioengineering technology using recombinant antigens, synthetic antigens, monospecific antibodies and polyclonal antibodies on immunochromatographic analytical scaffolds in conjunction with latex and colloidal metal particles. achieve our test development goals.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioPorto Diagnostics
United States · 6 relevant products
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 2 relevant products
Hangzhou Pefectech Biotechnology Co., Ltd.
China · 1 relevant product
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →16 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 112 closest product alternatives
BioPorto Diagnostics · United States
CE-marked in vitro diagnostic test for early detection of acute kidney injury using the NGAL biomarker. Provides rapid results to guide clinical interventions for kidney damage assessment in critically ill patients.
BioPorto Diagnostics · United States
Clinical chemistry-based assay for NGAL biomarker detection to aid in risk assessment and diagnosis of acute kidney injury. Provides objective measurement of kidney damage indicators in critically ill patient populations.
BioPorto Diagnostics · United States
CE-marked in vitro diagnostic test for early detection of acute kidney injury using the NGAL biomarker. Identifies kidney damage earlier than traditional serum creatinine and urine output methods, enabling timely clinical intervention.
109 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products